Microbiome
MICROBIOMICS
Synthetic Biology Technologies and Products
SYNTHETIC BIOLOGY
MAGIGENE has been authorized by Sun Yat-sen University for the use of patent Preparation and Use of Inducible Mutant Protein Based on Activation of Inducible Cytidine Deaminase. This system allows us to mutate the CDR sequence of VHH. By continuously mutating the yeast, we generate a diverse VHH library from which we can extract antigen-specific VHH using the yeast surface display method. Compared to traditional VHH screening from immune libraries of camelidae, the mutagenesis screening VHH system offers significant advantages in terms of cost, iteration, parallelism, and time-saving. Findrop Biosafety Technology (Guangzhou), a wholly-owned subsidiary of MAGIGENE, now implements this patented technology for nanobody screening, nanobody product development, and related technical services
News Dynamics
NEWS
Magi Gene
Magi Kefu
Contact Us
Address: Floor 13, Block B, Building 7, Phase 3, International Innovation Valley, Shenzhen
Address: 28th Floor, Building A, Guanzhou Life Science Center, Guangzhou International BioIsland
Address: 4F, Building 3, Phase 2, Guangzhou International Biological Island
Copyright©2023 Guangdong Magigene Biotechnology Co., Ltd.
SAF Coolest v1.3 设置面板 OBFSX-ZNUX-JVSQE-XEW
无数据提示
Sorry, the current column has no content for the time being.!
You can view other columns or returnHome Page